• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性风湿病患者首次心血管事件的发生率:CARMA 项目的前瞻性数据。

Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.

机构信息

Research Unit of Spanish Society of Rheumatology, Madrid, Spain.

Division of Rheumatology, Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Spain.

出版信息

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):731-739. Epub 2019 Jan 3.

PMID:30620291
Abstract

OBJECTIVES

To determine the incidence and risk factors of first cardiovascular event (CVE) in patients with chronic inflammatory rheumatic diseases (CIRD).

METHODS

Analysis of data after 2.5 years of follow-up from the prospective study CARMA project, that includes patients with CIRD [rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA)] and matched individuals without CIRD from 67 hospitals in Spain. CVE cumulative incidence per 1000 patients was calculated after 2.5 years from the start of the project. Weibull proportional hazard model was used to calculate hazard ratio (HR) and 95% confidence interval (95% CI) of the risk factors.

RESULTS

2595 (89.1%) patients completed the 2.5 years of follow-up visit. Cumulative incidence of CVE in patients with CIRD was 15.30 cases per 1000 patients (95% CI: 12.93-17.67), being higher in the subgroup with AS; 22.03 (95% CI: 11.01-33.04). Patients with AS (HR: 4.11; 95% CI: 1.07-15.79), those with older age (HR: 1.09; 95% CI: 1.05-1.13), systolic hypertension (HR: 1.02; 95% CI: 1.00-1.04) and long duration of the disease (HR: 1.07; 95% CI: 1.03-1.12) were at higher risk of first CVE during the 2.5 years of follow-up. In contrast, female gender was a protective factor (HR: 0.43; 95% CI: 0.18-1.00).

CONCLUSIONS

Among CIRD patients prospectively followed-up at rheumatology outpatient clinics, those with AS show higher risk of first CVE. Besides cardiovascular risk factors, such as hypertension, being a man and older as well as having a long disease duration increase the risk of CVE in patients with CIRD.

摘要

目的

确定慢性炎症性风湿病(CIRD)患者首次心血管事件(CVE)的发生率和风险因素。

方法

对前瞻性 CARMA 项目的 2.5 年随访数据进行分析,该项目包括来自西班牙 67 家医院的 CIRD 患者(类风湿关节炎(RA)、强直性脊柱炎(AS)和银屑病关节炎(PsA))和匹配的无 CIRD 个体。从项目开始后 2.5 年计算每 1000 例患者的 CVE 累积发生率。Weibull 比例风险模型用于计算风险因素的风险比(HR)和 95%置信区间(95%CI)。

结果

2595 例(89.1%)患者完成了 2.5 年的随访。CIRD 患者的 CVE 累积发生率为每 1000 例患者 15.30 例(95%CI:12.93-17.67),AS 亚组更高,为 22.03(95%CI:11.01-33.04)。AS 患者(HR:4.11;95%CI:1.07-15.79)、年龄较大(HR:1.09;95%CI:1.05-1.13)、收缩压升高(HR:1.02;95%CI:1.00-1.04)和疾病持续时间较长(HR:1.07;95%CI:1.03-1.12)的患者在 2.5 年随访期间首次发生 CVE 的风险更高。相比之下,女性是一种保护因素(HR:0.43;95%CI:0.18-1.00)。

结论

在风湿科门诊前瞻性随访的 CIRD 患者中,AS 患者首次 CVE 的风险更高。除了高血压等心血管危险因素外,男性、年龄较大以及疾病持续时间较长也会增加 CIRD 患者发生 CVE 的风险。

相似文献

1
Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.炎症性风湿病患者首次心血管事件的发生率:CARMA 项目的前瞻性数据。
Clin Exp Rheumatol. 2019 Sep-Oct;37(5):731-739. Epub 2019 Jan 3.
2
Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.西班牙风湿科门诊慢性炎症性风湿疾病患者的心血管发病率及相关危险因素:CARMA项目的基线数据
Semin Arthritis Rheum. 2015 Jun;44(6):618-26. doi: 10.1016/j.semarthrit.2014.12.002. Epub 2014 Dec 25.
3
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.在风湿免疫领域的心血管前瞻性研究(CARMA)中,炎症性风湿病患者的心血管死亡率和心血管事件发生率 - 5 年随访结果。
Rheumatology (Oxford). 2021 Jun 18;60(6):2906-2915. doi: 10.1093/rheumatology/keaa737.
4
Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.慢性炎症性风湿性疾病中的维生素D缺乏:风湿病心血管研究[CARMA]的结果
Arthritis Res Ther. 2015 Aug 14;17(1):211. doi: 10.1186/s13075-015-0704-4.
5
Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.生物制剂与炎症性关节炎心血管事件:一项前瞻性全国队列研究。
Arthritis Res Ther. 2018 Aug 7;20(1):171. doi: 10.1186/s13075-018-1669-x.
6
Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.炎性风湿病与药物使用障碍风险:瑞典基于登记的队列研究。
Clin Rheumatol. 2024 Jan;43(1):81-85. doi: 10.1007/s10067-023-06755-w. Epub 2023 Aug 28.
7
Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.银屑病或银屑病关节炎患者心血管疾病、自身免疫性疾病及其他疾病的患病率和发病率:一项使用临床实践研究数据链的回顾性研究
J Eur Acad Dermatol Venereol. 2015 May;29(5):955-63. doi: 10.1111/jdv.12742. Epub 2014 Oct 28.
8
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project.慢性炎症性风湿性疾病中的体重指数与疾病活动度:风湿病心血管研究(Carma)项目的结果
J Clin Med. 2021 Jan 20;10(3):382. doi: 10.3390/jcm10030382.
9
Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.强直性脊柱炎、银屑病关节炎和未分化脊柱关节炎是否与心血管事件风险增加相关?一项基于全国人群的前瞻性队列研究。
Arthritis Res Ther. 2017 May 18;19(1):102. doi: 10.1186/s13075-017-1315-z.
10
Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden.痛风、银屑病关节炎、类风湿关节炎和强直性脊柱炎患者的心血管危险因素:瑞典西部的横断面调查。
RMD Open. 2021 May;7(2). doi: 10.1136/rmdopen-2021-001568.

引用本文的文献

1
Cardiovascular comorbidities in spondyloarthritis.脊柱关节炎的心血管合并症。
Clin Rheumatol. 2023 Oct;42(10):2611-2620. doi: 10.1007/s10067-022-06473-9. Epub 2022 Dec 13.
2
Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型与系统性红斑狼疮患者的疾病活动和损伤有关。
Ther Adv Musculoskelet Dis. 2020 Nov 28;12:1759720X20975904. doi: 10.1177/1759720X20975904. eCollection 2020.